Joseph Santangelo
Plus aucun poste en cours
Profil
Joseph Santangelo is the founder of Singvax Pte Ltd.
Prior to founding Singvax, he worked as a Principal at Microscience Ltd.
and as the Chief Operating Officer at Inviragen, Inc. He holds a doctorate degree from the University of Cape Town, a graduate degree from the University of Vermont, and an undergraduate degree from The State University of New York.
Anciens postes connus de Joseph Santangelo
| Sociétés | Poste | Fin |
|---|---|---|
Singvax Pte Ltd.
 Singvax Pte Ltd. Medical SpecialtiesHealth Technology Singvax Pte Ltd. develops vaccines for infectious diseases. Its products include Chikungunya, Japanese Encephalitis, and Enterovirus 71. The company was founded in 2004 and is headquartered in Singapore | Fondateur | 06/10/2009 |
Microscience Ltd.
 Microscience Ltd. Pharmaceuticals: MajorHealth Technology Microscience is an emerging vaccine company which is primarily involved in the discovery and development of innovative, rationally designed vaccines and immunotherapeutics for the prevention and treatment of disease in areas that the Company believes to represent a significant opportunity for new vaccines | Corporate Officer/Principal | - |
Inviragen, Inc.
 Inviragen, Inc. BiotechnologyHealth Technology Inviragen, Inc. developed life-saving vaccine to protect against infectious diseases worldwide. The company was founded by Dan T. Stinchcomb and Jorge Osorio in November 2003 and was headquartered in Fort Collins, CO. | Directeur des opérations | - |
Formation de Joseph Santangelo
| University of Vermont | Graduate Degree |
| University of Cape Town | Doctorate Degree |
| The State University of New York | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Microscience Ltd.
Microscience Ltd. Pharmaceuticals: MajorHealth Technology Microscience is an emerging vaccine company which is primarily involved in the discovery and development of innovative, rationally designed vaccines and immunotherapeutics for the prevention and treatment of disease in areas that the Company believes to represent a significant opportunity for new vaccines | Health Technology |
Singvax Pte Ltd.
Singvax Pte Ltd. Medical SpecialtiesHealth Technology Singvax Pte Ltd. develops vaccines for infectious diseases. Its products include Chikungunya, Japanese Encephalitis, and Enterovirus 71. The company was founded in 2004 and is headquartered in Singapore | Health Technology |
Inviragen, Inc.
Inviragen, Inc. BiotechnologyHealth Technology Inviragen, Inc. developed life-saving vaccine to protect against infectious diseases worldwide. The company was founded by Dan T. Stinchcomb and Jorge Osorio in November 2003 and was headquartered in Fort Collins, CO. | Health Technology |